サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1565015

がん情報システムの世界市場

Oncology Information Systems

出版日
ページ情報
英文 193 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
がん情報システムの世界市場
出版日: 2024年10月04日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 193 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

がん情報システムの世界市場は2030年までに64億米ドルに到達

2023年に42億米ドルと推定されるがん情報システムの世界市場は、2023年から2030年にかけてCAGR 6.1%で成長し、2030年には64億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである「ソフトウェアコンポーネント」は、CAGR 6.7％を記録し、分析期間終了時には55億米ドルに達すると予測されます。サービスコンポーネント分野の成長率は、分析期間でCAGR 3.2％と推定されます。

米国市場は12億米ドル、中国はCAGR 5.7％で成長すると予測

米国のがん情報システム市場は、2023年に12億米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2023-2030年のCAGR 5.7%を牽引し、2030年には予測市場規模9億9,470万米ドルに達すると予測されます。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ5.7%と4.7%と予測されています。欧州では、ドイツがCAGR 4.8%で成長すると予測されています。

世界のがん情報システム市場- 主要動向と促進要因まとめ

がん情報システムとは何か、なぜ重要なのか？

がん情報システム（OIS）は、包括的ながん治療を管理するために設計された専門的なデジタルプラットフォームです。これらのシステムは、患者データ管理、治療計画、臨床ワークフロー、意思決定支援ツールなどの様々な機能を単一のソリューションに統合しています。患者記録の文書化を合理化し、治療プロトコルを追跡し、集学的チーム間のコミュニケーションを改善することで、OISはがん治療の質と効率を高める上で重要な役割を果たしています。これらのシステムは病院、がん治療センター、研究機関などで広く採用されており、精密医療を促進し、患者の転帰をモニターし、進化する治療ガイドラインの遵守を保証しています。世界のがん罹患率の増加に伴い、がん情報システムはこの複雑な疾患との闘いに不可欠なツールとなりつつあります。

技術の進歩はどのようにがん情報システムを形成しているのでしょうか？

技術の進歩は、進化するがん情報システムの中核であり、治療計画、データ分析、患者ケアの大幅な改善を推進しています。最も革新的なイノベーションの1つは、人工知能（AI）と機械学習アルゴリズムの統合であり、膨大な量の患者データを分析し、治療結果を予測することで、臨床医がパーソナライズされた治療計画を策定するのを支援します。さらに、OISプラットフォームは相互運用性を高めており、異なるヘルスケアシステム、電子カルテ（EHR）、医療画像技術間でのシームレスなデータ交換を可能にしています。クラウドベースのがん情報システムもまた、アクセス性、拡張性、データセキュリティを強化し、人気を集めています。遠隔医療が普及するにつれ、OISプラットフォームは遠隔患者モニタリングツールを統合し、腫瘍医がリアルタイムで患者の経過を追跡し、それに応じて治療プロトコルを調整することを可能にしています。

なぜヘルスケアでがん情報システムの採用が増加しているのか？

世界のがん罹患率の上昇により、効率的で包括的ながん治療管理システムに対する需要が高まり、OISの採用が進んでいます。このようなシステムは、様々な専門医間の連携が重要な、複雑で集学的ながん治療において特に有用です。ヘルスケア産業が価値に基づく治療へとシフトする中、がん情報システムは医療提供者が治療結果、患者のアドヒアランス、医療費全体を追跡するのに役立ち、より費用対効果の高い、結果重視のがん治療に貢献します。さらに、個人の遺伝子プロファイルに合わせた治療を行うプレシジョン・オンコロジーが重視されるようになってきており、個別化された治療計画に必要な膨大な遺伝子データや臨床データを管理するためにOISに大きく依存しています。OISを放射線療法や化学療法システムと統合することで、治療の精度と効率がさらに高まる。

がん情報システム市場の成長を促進する要因は？

がん情報システム市場の成長は、世界のがん負担の増加や協調的ながん治療管理のニーズの高まりなど、いくつかの要因によってもたらされます。AIを活用した治療計画、クラウドベースのプラットフォーム、遠隔モニタリングツールなどの技術的進歩により、OISの機能性とアクセシビリティが大幅に向上しており、現代のがん診療に欠かせないものとなっています。精密医療と個別化がん治療へのシフトも重要な促進要因であり、OISはゲノミクスと個別化治療計画に関連する複雑なデータセットの管理に不可欠です。さらに、ヘルスケアプロバイダーは、文書化、治療プロトコル、患者の安全性に関する規制要件を満たすために、OISの採用を増やしています。包括的ながん治療への需要が高まり続ける中、OISプラットフォームはがん治療に不可欠な要素になりつつあり、この市場の持続的成長を牽引しています。

調査対象企業の例（注目の43社）

  • Accuray, Inc.
  • Cerner Corporation
  • Elekta AB
  • Epic Systems Corporation
  • Flatiron Health, Inc.
  • Koninklijke Philips NV
  • McKesson Corporation
  • RAYSEARCH Laboratories AB
  • Varian Medical Systems, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP13703

Global Oncology Information Systems Market to Reach US$6.4 Billion by 2030

The global market for Oncology Information Systems estimated at US$4.2 Billion in the year 2023, is expected to reach US$6.4 Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2023-2030. Software Component, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$5.5 Billion by the end of the analysis period. Growth in the Services Component segment is estimated at 3.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.2 Billion While China is Forecast to Grow at 5.7% CAGR

The Oncology Information Systems market in the U.S. is estimated at US$1.2 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$994.7 Million by the year 2030 trailing a CAGR of 5.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.7% and 4.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.

Global Oncology Information Systems Market – Key Trends & Drivers Summarized

What Are Oncology Information Systems and Why Are They Crucial?

Oncology information systems (OIS) are specialized digital platforms designed to manage comprehensive cancer care. These systems integrate various functions, including patient data management, treatment planning, clinical workflows, and decision support tools, into a single solution. By streamlining the documentation of patient records, tracking treatment protocols, and improving communication between multidisciplinary teams, OIS play a vital role in enhancing the quality and efficiency of oncology care. These systems are widely adopted by hospitals, cancer treatment centers, and research institutions, where they facilitate precision medicine, monitor patient outcomes, and ensure compliance with evolving treatment guidelines. With the increasing incidence of cancer globally, oncology information systems are becoming an essential tool in the fight against this complex disease.

How Are Technological Advancements Shaping Oncology Information Systems?

Technological advancements are at the core of the evolving oncology information systems landscape, driving significant improvements in treatment planning, data analytics, and patient care. One of the most transformative innovations has been the integration of artificial intelligence (AI) and machine learning algorithms, which assist clinicians in developing personalized treatment plans by analyzing vast amounts of patient data and predicting outcomes. Additionally, OIS platforms are becoming more interoperable, allowing seamless data exchange between different healthcare systems, electronic health records (EHR), and medical imaging technologies. Cloud-based oncology information systems are also gaining traction, offering enhanced accessibility, scalability, and data security. As telemedicine becomes more prevalent, OIS platforms are integrating remote patient monitoring tools, enabling oncologists to track patient progress in real time and adjust treatment protocols accordingly.

Why Is the Adoption of Oncology Information Systems Increasing in Healthcare?

The rising incidence of cancer worldwide has increased the demand for efficient and comprehensive cancer care management systems, driving the adoption of OIS. These systems are particularly valuable in complex, multidisciplinary cancer treatments, where coordination between various specialists is critical. As the healthcare industry shifts towards value-based care, oncology information systems help providers track treatment outcomes, patient adherence, and overall healthcare costs, contributing to more cost-effective and outcome-driven cancer care. Moreover, the growing emphasis on precision oncology, which tailors treatments to the individual’s genetic profile, relies heavily on OIS to manage the vast amounts of genetic and clinical data required for personalized treatment plans. The integration of OIS with radiation therapy and chemotherapy systems further enhances treatment accuracy and efficiency.

What Factors Are Driving Growth in the Oncology Information Systems Market?

The growth in the oncology information systems market is driven by several factors, including the rising global cancer burden and the increasing need for coordinated cancer care management. Technological advancements, such as AI-driven treatment planning, cloud-based platforms, and remote monitoring tools, are significantly improving the functionality and accessibility of OIS, making them essential in modern oncology practices. The shift toward precision medicine and personalized cancer therapies is another key driver, as OIS are indispensable for managing the complex data sets associated with genomics and individualized treatment plans. Additionally, healthcare providers are increasingly adopting OIS to meet regulatory requirements for documentation, treatment protocols, and patient safety. As the demand for comprehensive cancer care continues to grow, OIS platforms are becoming a vital component of cancer treatment, driving sustained growth in this market.

Select Competitors (Total 43 Featured) -

  • Accuray, Inc.
  • Cerner Corporation
  • Elekta AB
  • Epic Systems Corporation
  • Flatiron Health, Inc.
  • Koninklijke Philips NV
  • McKesson Corporation
  • RAYSEARCH Laboratories AB
  • Varian Medical Systems, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Oncology Information Systems - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Focus on Personalized Cancer Treatment Drives Demand for Advanced Oncology Information Systems (OIS)
    • Increased Adoption of Electronic Health Records (EHR) Integration Expands Addressable Market for OIS Solutions
    • Rising Cancer Incidence Globally Spurs Growth in Oncology Information Systems Deployment Across Healthcare Providers
    • Advancements in AI-Driven Decision Support Systems Propel Growth of Oncology Information Systems for Treatment Planning
    • Value-Based Care Models Strengthen the Business Case for Comprehensive Oncology Information Systems
    • Increased Focus on Precision Medicine Accelerates Demand for Data-Driven Oncology Information Systems
    • Growing Adoption of Cloud-Based Oncology Information Systems Enhances Scalability and Access
    • Rising Need for Multidisciplinary Care Coordination Drives Demand for Integrated Oncology Information Systems
    • Advances in Genomic Data Integration in OIS Platforms Propel Growth in Molecular Oncology Diagnostics
    • Growing Emphasis on Patient-Centric Care Models Expands the Addressable Market for Oncology Information Systems
    • Increasing Utilization of Telemedicine in Cancer Care Spurs Growth in Cloud-Enabled Oncology Information Systems
    • Rising Need for Advanced Reporting and Analytics in Oncology Research and Clinical Trials Generates Demand for OIS Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Oncology Information Systems Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Oncology Information Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Oncology Information Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Oncology Information Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Medical Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Medical Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Medical Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Radiation Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Radiation Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Radiation Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Surgical Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Surgical Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Surgical Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals & Oncology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospitals & Oncology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Hospitals & Oncology Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Research Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Oncology Information Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Oncology Information Systems by Segment - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Oncology Information Systems by Segment - Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Oncology Information Systems by Segment - Percentage Breakdown of Value Sales for Software and Services for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Oncology Information Systems by Application - Percentage Breakdown of Value Sales for Medical Oncology, Radiation Oncology and Surgical Oncology for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Oncology Information Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Oncology Clinics, Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Oncology Information Systems by Segment - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Oncology Information Systems by Segment - Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Oncology Information Systems by Segment - Percentage Breakdown of Value Sales for Software and Services for the Years 2014, 2024 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Oncology Information Systems by Application - Percentage Breakdown of Value Sales for Medical Oncology, Radiation Oncology and Surgical Oncology for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Oncology Information Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Oncology Clinics, Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Oncology Information Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Oncology Information Systems by Segment - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Oncology Information Systems by Segment - Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Oncology Information Systems by Segment - Percentage Breakdown of Value Sales for Software and Services for the Years 2014, 2024 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Oncology Information Systems by Application - Percentage Breakdown of Value Sales for Medical Oncology, Radiation Oncology and Surgical Oncology for the Years 2014, 2024 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Oncology Information Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Oncology Clinics, Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Oncology Information Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Oncology Information Systems by Segment - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Oncology Information Systems by Segment - Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Oncology Information Systems by Segment - Percentage Breakdown of Value Sales for Software and Services for the Years 2014, 2024 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Oncology Information Systems by Application - Percentage Breakdown of Value Sales for Medical Oncology, Radiation Oncology and Surgical Oncology for the Years 2014, 2024 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Oncology Information Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Oncology Clinics, Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Oncology Information Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Oncology Information Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Oncology Information Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Oncology Information Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Oncology Information Systems by Segment - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Oncology Information Systems by Segment - Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Oncology Information Systems by Segment - Percentage Breakdown of Value Sales for Software and Services for the Years 2014, 2024 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Oncology Information Systems by Application - Percentage Breakdown of Value Sales for Medical Oncology, Radiation Oncology and Surgical Oncology for the Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Oncology Information Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Oncology Clinics, Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Oncology Information Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Oncology Information Systems by Segment - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Oncology Information Systems by Segment - Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: France 16-Year Perspective for Oncology Information Systems by Segment - Percentage Breakdown of Value Sales for Software and Services for the Years 2014, 2024 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: France 16-Year Perspective for Oncology Information Systems by Application - Percentage Breakdown of Value Sales for Medical Oncology, Radiation Oncology and Surgical Oncology for the Years 2014, 2024 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Oncology Information Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Oncology Clinics, Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Oncology Information Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Oncology Information Systems by Segment - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Oncology Information Systems by Segment - Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Germany 16-Year Perspective for Oncology Information Systems by Segment - Percentage Breakdown of Value Sales for Software and Services for the Years 2014, 2024 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Oncology Information Systems by Application - Percentage Breakdown of Value Sales for Medical Oncology, Radiation Oncology and Surgical Oncology for the Years 2014, 2024 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Oncology Information Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Oncology Clinics, Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Oncology Information Systems by Segment - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Oncology Information Systems by Segment - Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Italy 16-Year Perspective for Oncology Information Systems by Segment - Percentage Breakdown of Value Sales for Software and Services for the Years 2014, 2024 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Oncology Information Systems by Application - Percentage Breakdown of Value Sales for Medical Oncology, Radiation Oncology and Surgical Oncology for the Years 2014, 2024 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Oncology Information Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Oncology Clinics, Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Oncology Information Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Oncology Information Systems by Segment - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Oncology Information Systems by Segment - Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: UK 16-Year Perspective for Oncology Information Systems by Segment - Percentage Breakdown of Value Sales for Software and Services for the Years 2014, 2024 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Oncology Information Systems by Application - Percentage Breakdown of Value Sales for Medical Oncology, Radiation Oncology and Surgical Oncology for the Years 2014, 2024 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Oncology Information Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Oncology Clinics, Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Oncology Information Systems by Segment - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Rest of Europe Historic Review for Oncology Information Systems by Segment - Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Rest of Europe 16-Year Perspective for Oncology Information Systems by Segment - Percentage Breakdown of Value Sales for Software and Services for the Years 2014, 2024 & 2030
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Rest of Europe Historic Review for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Rest of Europe 16-Year Perspective for Oncology Information Systems by Application - Percentage Breakdown of Value Sales for Medical Oncology, Radiation Oncology and Surgical Oncology for the Years 2014, 2024 & 2030
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Rest of Europe 16-Year Perspective for Oncology Information Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Oncology Clinics, Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Oncology Information Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Oncology Information Systems by Segment - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific Historic Review for Oncology Information Systems by Segment - Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Asia-Pacific 16-Year Perspective for Oncology Information Systems by Segment - Percentage Breakdown of Value Sales for Software and Services for the Years 2014, 2024 & 2030
    • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Asia-Pacific Historic Review for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Asia-Pacific 16-Year Perspective for Oncology Information Systems by Application - Percentage Breakdown of Value Sales for Medical Oncology, Radiation Oncology and Surgical Oncology for the Years 2014, 2024 & 2030
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Asia-Pacific 16-Year Perspective for Oncology Information Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Oncology Clinics, Research Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 131: Rest of World Recent Past, Current & Future Analysis for Oncology Information Systems by Segment - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of World Historic Review for Oncology Information Systems by Segment - Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of World 16-Year Perspective for Oncology Information Systems by Segment - Percentage Breakdown of Value Sales for Software and Services for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of World Recent Past, Current & Future Analysis for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of World Historic Review for Oncology Information Systems by Application - Medical Oncology, Radiation Oncology and Surgical Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of World 16-Year Perspective for Oncology Information Systems by Application - Percentage Breakdown of Value Sales for Medical Oncology, Radiation Oncology and Surgical Oncology for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of World Recent Past, Current & Future Analysis for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of World Historic Review for Oncology Information Systems by End-Use - Hospitals & Oncology Clinics, Research Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of World 16-Year Perspective for Oncology Information Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Oncology Clinics, Research Centers and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION